Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Gilat Reports Third Quarter 2025 Results
-
Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer
-
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
-
Zenas BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Bitdeer Reports Fire Incident at Massillon Development Site
-
Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
-
Bunzl Canada Earns 2025 Great Place to Work® Certification
-
Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests
-
Fancamp Announces New Partnership With Harfang and Initiation of Strategic Corporate Reorganization
-
ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights
-
USA Rare Earth Announces UK Regulatory Approval for Acquisition of Less Common Metals (LCM)
-
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Monogram Health Announces New Executives to Oversee its U.S. Operations
-
Home Resource Becomes Exclusive US Distributor of Kettnaker Soma Media System
-
Bexorg Strengthens Leadership Team with Appointment of Sean Murphy, Ph.D., as Chief Technology Officer
-
BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s Disease
-
DAVIDsTEA Announces $3.0 Million Private Placement and $2.7 Million Revenue-Linked Financing
-
SEED Therapeutics Receives IND Clearance from China’s NMPA for ST-01156
-
Opus Genetics Announces Financial Results for Third Quarter 2025 and Provides Corporate Update
-
Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
-
Ocular Therapeutix™ to Participate in November and December Investor Conferences
-
Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update
-
BeyondSpring Reports Third‑Quarter 2025 Financial Results and Provides Corporate Update
-
GlobalFoundries Reports Third Quarter 2025 Financial Results
-
Goranson Bain Ausley Named #2 Top Workplace in Dallas Morning News 2025 Ranking
-
Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
-
ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights
-
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
-
Prospect Credit REIT Provides $18.0 Million to Class A Stabilized Cash-Flowing Multifamily Property in New Rochelle, NY
-
Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results
-
Amplify ETFs Files for the Amplify HACK Cybersecurity Covered Call ETF (HAKY)
-
AleAnna, Inc. Reports Third Quarter 2025 Results and Provides Update on Longanesi Field
-
Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update
-
Acumen Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Highlights
-
Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited)
-
Dispatch Energy Acquires Green Lantern Solar (GLS), Extending its Distributed Generation Footprint Across Nine States
-
Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs
-
TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
High Roller Announces Appointment of Jake Francis as Chief Operating Officer
-
Destination XL Group, Inc. to Announce Third Quarter 2025 Financial Results on Thursday, December 4, 2025
-
PayCargo and IBS Software Strengthen Long-Term Collaboration to Advance Air Cargo
-
Apellis Announces 5-Year GALE Data Showing SYFOVRE® (pegcetacoplan injection) Delayed Progression of Geographic Atrophy by ~1.5 Years
-
Energous Wireless Power Solutions Reports Third Quarter 2025 Results
-
Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights
-
Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference
-
GlobalFoundries Reports Third Quarter 2025 Financial Results
-
AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans
-
Transom Acquires Binswanger Glass, Accelerating Next Phase of Growth for Leading U.S. Glazing Company
-
Climb Channel Solutions Announces Strategic Partnership with Liongard
